Cell-permeable nicotinamide adenine dinucleotides for exploration of cellular protein ADP-ribosylation

12 June 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Posttranslational modifications (PTMs) greatly enhance the functional diversity of proteins, surpassing the number of gene-encoded variations. One intriguing PTM is ADP-ribosylation, which utilizes nicotinamide adenine dinucleotide (NAD+) as a substrate and is essential in cell signaling pathways regulating cellular responses. Here, we report the first cell-permeable NAD+ analogs and demonstrate their utility for investigating cellular ADP-ribosylation. Using a desthiobiotin-labelled analog for affinity enrichment of proteins that are ADP-ribosylated in living cells under oxidative stress, we identified protein targets associated with host-virus interactions, DNA damage and repair, protein biosynthesis, and ribosome biogenesis. Most of these targets have been noted in various literature sources, highlighting the potential of our probes for cellular ADP-ribosylome studies.

Keywords

ADP-ribosylation
NAD+
cell-permeability
cellular delivery
PARP
molecular probes

Supplementary materials

Title
Description
Actions
Title
General Supporting Information
Description
Experimental procedures, synthesis of compounds with NMR and HR MS characterization, and additional figures.
Actions
Title
Proteomics
Description
1465 identified proteins, including 121 significant proteins found in the samples with probe under oxidative stress
Actions
Title
DAVID Analysis
Description
The results of DAVID analysis of significant proteins
Actions
Title
Comparison with literature
Description
Comparison of enriched significant proteins with the literature data
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.